Dáil Éireann Debate, Thursday - 14 May 2026
567. Deputy Ken O'Flynn asked the Minister for Health whether any monetary approval thresholds exist within the treatment abroad scheme requiring additional sign-off for high-cost procedures; the officials or grades responsible for such approvals; and if she will provide the thresholds currently applied. [36018/26]
View answer568. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme operates any formal value-for-money assessment process prior to approving exceptionally high-cost procedures abroad; and if so, the methodology used. [36019/26]
View answer569. Deputy Ken O'Flynn asked the Minister for Health the number of Treatment Abroad Scheme applications approved with an estimated cost exceeding in each year since 2020 (details supplied). [36020/26]
View answer570. Deputy Ken O'Flynn asked the Minister for Health whether any applications under the Treatment Abroad Scheme have been refused wholly or partly on financial, budgetary, or proportionality grounds since 2020; and if she will provide annual figures. [36021/26]
View answer571. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains a central register of high-cost overseas procedures approved under the Treatment Abroad Scheme; and if so, the governance and reporting arrangements applying to that register. [36022/26]
View answer572. Deputy Ken O'Flynn asked the Minister for Health the dates of all internal audit reviews, Comptroller and Auditor General examinations, or other formal oversight reviews conducted in respect of the Treatment Abroad Scheme since 2020; and if copies of findings or recommendations will be provided. [36023/26]
View answer573. Deputy Ken O'Flynn asked the Minister for Health whether any risk assessment has been conducted regarding financial exposure arising from exceptionally high-cost procedures funded under the Treatment Abroad Scheme; and if so, whether she will provide details. [36024/26]
View answer574. Deputy Ken O'Flynn asked the Minister for Health whether the Treatment Abroad Scheme has any specific governance pathway for novel, experimental, or highly specialised procedures abroad involving significant State expenditure. [36025/26]
View answer575. Deputy Ken O'Flynn asked the Minister for Health whether the Treatment Abroad Scheme maintains procedure-specific coding or categorisation for any surgical specialties funded abroad; and if so, to provide the categories recorded. [36026/26]
View answer577. Deputy Ken O'Flynn asked the Minister for Health whether any legal, GDPR, administrative, or policy barrier prevents the Treatment Abroad Scheme from recording anonymised procedure-category data for overseas gender-related surgeries. [36028/26]
View answer579. Deputy Ken O'Flynn asked the Minister for Health whether her Department has requested the introduction of structured reporting or coding mechanisms relating to gender affirmation procedures funded abroad under the Treatment Abroad Scheme. [36030/26]
View answer580. Deputy Ken O'Flynn asked the Minister for Health the total annual expenditure under the Treatment Abroad Scheme on overseas gender-related surgical referrals for each year from 2020 to date. [36031/26]
View answer581. Deputy Ken O'Flynn asked the Minister for Health whether the Treatment Abroad Scheme records the age profile of persons approved for overseas gender affirmation surgeries. [36032/26]
View answerI propose to take Questions Nos. 567 to 575, inclusive, 577 and 579 to 581, inclusive, together.
As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.
